COVID-19 Monoclonal Antibody Treatment Information for Long Term Care & Assisted Living Facilities
Maine Department of Health & Human Services sent this bulletin at 01/03/2022 01:30 PM ESTHaving trouble viewing this email? View it as a Web page.
COVID-19 Monoclonal Antibody Treatment Information
for Long Term Care & Assisted Living Facilities
January 3, 2022
The Maine Department of Health and Human Services has assembled an information toolkit for Long Term Care, Assisted Living Facilities, and Group Homes regarding the Monoclonal Antibody (mAb) Treatment available to residents.
For questions or other related issues, providers may also contact Dr Lisa Letourneau at ME DHHS:
lisa.letourneau@maine.gov. For more information on mAb therapies, visit https://combatcovid.hhs.gov